Delivery Order SPE2DB22D3009-SPE2DB24FAK57
- Not listed
- This federal contract award, worth $4,486.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the...
- This federal contract award, valued at $10,582.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages, which are used to treat nausea and vomiting. The award is a delivery order under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through December...
- This federal contract award, valued at $12,457.19, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,179 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $6,852.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting associated with certain medical treatments. The contract is a Firm Fixed Price Delivery Order with a completion date of February 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,235.55 delivery order is for the supply of 4 mg Ondansetron ODT tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of April 18, 2023 and is a firm fixed-price delivery order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc. valued at up to $999,999,999.00. This IDC serves as the...
- This federal contract award, valued at $1,659.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,731,832 units of the pharmaceutical drug Ondansetron ODT 4 MG Tablet, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of August 8, 2023 and is a firm fixed-price delivery order. It is not associated with any set-aside requirements, indicating full...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,997.94 firm fixed-price delivery order is for Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,591.80 Firm Fixed Price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award, valued at $1,855.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,590,528 tablets of Ondansetron HCL 4 mg, a generic pharmaceutical product used to treat nausea and vomiting. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between the DLA Troop Support...
- This federal contract award, valued at $39,919.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB24FAK57Delivery Order
This federal contract award, valued at $1,940.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting, to support military treatment facilities and other federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense and other federal agencies. The contract was awarded on an unrestricted basis, with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/5/23 |